CERTAIN CONFIDENTIAL INFORMATION CONTAINED IN THIS DOCUMENT, MARKED BY [***] HAS BEEN OMITTED BECAUSE IT IS NOT MATERIAL AND WOULD LIKELY CAUSE COMPETITIVE HARM TO THE REGISTRANT IF PUBLICLY DISCLOSED. ASSET TRANSFER AGREEMENT among ALKERMES PHARMA...Asset Transfer Agreement • April 4th, 2023 • Baudax Bio, Inc. • Services-misc health & allied services, nec • New York
Contract Type FiledApril 4th, 2023 Company Industry JurisdictionThis ASSET TRANSFER AGREEMENT (as may be amended, restated, supplemented or otherwise modified in accordance with Section 7.6, this “Agreement”), dated as of March 29, 2023 (the “Agreement Date”), is among Alkermes Pharma Ireland Limited, a limited liability company organized under the laws of Ireland, whose registered number is 448848 and whose registered address is Connaught House, 1 Burlington Road, Dublin 4, Ireland (“Purchaser”), and Baudax Bio, Inc., a Pennsylvania corporation, with an address of 490 Lapp Road, Malvern PA 19355 (“Seller”).